MedPath

The effect of curcumin (a substance extracted from turmeric) on the immune system and clinical signs in patients with rheumatoid arthritis

Phase 2
Conditions
Rheumatoid Arthritis.
Rheumatoid arthritis, unspecified
M06.9
Registration Number
IRCT20220309054225N1
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
30
Inclusion Criteria

Patients are women
The age range is between 18-65 years
Measured by the European American College Rheumatology Criteria (EULAR-ACR) by a rheumatologist
Their DAS (disease activity scort28) is between 8.2 and 5, which is assessed by a rheumatologist.

Exclusion Criteria

Refusal to give informed consent
Chronic Diseases affecting ESR, CRP levels such as diabetes and heart disease
Pregnancy and lactation
Nervous disorders
Abnormal Creatinine (greater than 1/5)
Abnormal liver enzymes (AST-ALT) (3 times normal)

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath